Topic

Articles

Dr. Randall N. Hyer, SVP Global Medical Affairs at Moderna, talks about the strategies that have helped the company grow from startup to multi-billion-dollar firm in a decade.

Determining the Right Combination of Employees and New Technologies at Moderna

Sebastien Noel is Director, Multichannel Strategy at Veeva.

Companies now have a unique opportunity to rethink their customer engagement strategy and find new techniques to serve healthcare professionals more effectively.

The New Era of HCP Engagement: What’s Next on the Path to Digital Excellence

Leslie Rotz is Director, Digital Strategy & Operations, 

Content generation on pharma companies social media channels started with sharing links to recent publications and conference presentations. But what is the next step? How can the industry evolve from data dissemination to true two-way engagement?

Mastering Social Media for Medical Affairs

Anita Kawatra, Chief Corporate Affairs Officer at nference, has more than two decades of experience as a leader in the life sciences and global public health sectors, holding senior management positions across the pharmaceutical and biotechnology industries. She was a founding executive of Inheris Biopharma and previously served in global roles at Elan Pharmaceuticals, Prothena Biosciences, Merck & Co. and the International AIDS Vaccine Initiative.

Prior to her work in biopharmaceuticals, she served in the administrations of New York City Mayor David Dinkins and New York Governor Mario Cuomo.

Ms. Kawatra is a board member of the New York City Health and Hospitals Corporation, the largest public health system in the U.S., Sanctuary for Families and GrowNYC. In 2020, she was named among the 100 most influential Asian Americans in New York politics and policy. For 10 years, she served as an adjunct professor at New York University. She holds a master’s degree from Columbia University and a bachelor’s degree from Yale University.

Anita Kawatra discusses advancing clinical and pharmaceutical progress while protecting patient privacy.

AI-Powered De-Identification and Data Analysis

's Online and European Editor. He can be reached at jupton@mjhlifesciences.com

Accelerated implementation of AI platforms among pharma sales teams has highlighted the importance of the human factor.

Managing the People Side of AI Adoption

. Kate Beale is a senior policy director in Crowell & Moring's Government Affairs Group and affiliated with C&M International.

What can both public and private sector stakeholders learn from current trends to accelerate innovation around the COVID-19 pandemic and other emerging global health threats, including antimicrobial resistance?

Advancing Health Innovation in 2022: Where Should We Focus?

Simon Bates is a life sciences expert at 

The next few years will require life science companies to bring consumer-facing digital services to the core of their corporate competence, rather than leaving it at the periphery of their business capabilities.

Building Healthcare Consumers’ Trust in Personalized Digital and Data-Led Services

Jeremy Lovelace is the founder and director of 

Computer-based simulations are a great approach to pharmaceutical sales training because they are engaging, realistic and help develop critical skills for a data-driven world, writes Jeremy Lovelace.

Simulations and Pharma Sales Training

Wesam Badran is National Solutions Manager, UK & Ireland, BD.

Wesam Badran looks at how the UK NHS can collaborate with pharma and med-tech partners to encourage digital innovation.

Realizing the NHS’s Digital Potential

Clay Hausmann is CMO and SVP, Strategic Alliances, Aktana.

Grünenthal‘s Florent Edouard talks about AI‘s “key role in the future of marketing.”

Technology